Managing Our business Responsibility
 

By conducting our business responsibly and transparently, we establish ourselves as the leader and partner of choice in managing kidney care in a value based system. We must continuously create clinical value for our partners and patients that translates to economic value for all of us. Our approach is guided by evolving best practices and feedback from our stakeholders on topics identified as vital to our shared success.

 

financial management


63k+

U.S. employees and contractors completed compliance policy training.

financial management


46k+

U.S. employees completed at least 14 annual health and safety training programs based on job description and role.

financial management


62k+

U.S. employees and contractors participated in trainings on Data Privacy and Security.

Governance

financial management


global operations and policies


We develop policies and targets to drive progress on our commitments. Key policies and standards include, but are not limited to:

 

Responsible Management

Patient Safety

Employee Health and Safety

COMPLIANCE PROGRAM

GLOBAL SUPPLIER CODE OF CONDUCT

financial management

DATA PRIVACY AND CYBERSECURITY

In March 2018 we established our Information Security Office and appointed a Chief Information Security Officer who partners with executive leadership to deploy trusted solutions that strengthen and streamline our approach to data privacy and cybersecurity

POLITiCAL ADVOCACY

disaster response

Providing Diagnostic testing for COVID-19

Research and innovation

 

 

renal therapies group (RTG)


Our Clinical Research and Medical Affairs team co-authored 28 scientific and medical publications in support of our products.

 

frenova renal research


In the world of kidney disease and related disorders, Frenova Renal Research is a site management organization and the largest provider of investigators, chronic kidney disease (CKD) patients, end stage renal disease (ESRD) patients, and data assets for clinical trials. In 2020, Frenova enrolled 786 patients across 44 studies, a 21% increase in patients from 2019. 

 

renal research institute


Our Renal Research Institute (RRI) is committed to helping people with CKD and ESRD lead fuller, more active, and vibrant lives. We strive to achieve this goal by not only offering the best care possible, but also in giving our patients an option to enroll in research studies, which RRI initiates or opts to participate in. After shifting focus toward the pandemic in 2020, RRI had its research published in six peer-review publications and helped advance novel SARS-CoV-2 pool testing strategies.

 

INVESTING IN INNOVATION


Fresenius Medical Care Ventures invests in start-ups and early-stage companies in the healthcare sector. The investments are targeted to support Fresenius Medical Care’s corporate strategy to grow continuously in our core business and to expand into new business areas. Fresenius Medical Care Ventures is complementing the corporate activities in external innovation.

LEARN MORE

 

RESEARCH FELLOWSHIP FOR NEW KIDNEY DISEASE TREATMENTS


To advance new research in kidney disease and to help find a cure, the American Society of Nephrology (ASN) established The Ben J. Lipps Research Fellowship as part of its KidneyCure foundation. The fellowship is named after the former CEO of Fresenius Medical Care North America. Since its establishment in 2012, we have contributed $10 million and supported 35 unique studies. The program supports research over a two-year period, with five new fellowships funded annually. In 2021, the Ben J. Lipps Research Fellowship Program received 46 applications and awarded 10 new research fellowship grants. 

LEARN MORE

 

Artificial Intelligence Solutions in Nephrology 


Artificial Intelligence (AI), data science, and advanced analytics are helping make advances in the treatment of chronic kidney disease care and across healthcare at large. By leveraging big data to accelerate AI solutions for kidney disease, researchers, data scientists, and practitioners are developing clinical tools that enhance patient care. Throughout the organization, we’re using advanced analytics to support clinical decision making with a suite of more than 20 different models. Some of these AI-based tools include models to reduce hospitalizations, provide insights on who may be ideal in-center dialysis patients who would do well on home modalities, identify patient acuity according to social workers and dietitians, and predict peritoneal dialysis technique failure.

LEARN MORE

Contributing to the United Nations Sustainable Development Goals

All corporate responsibility data is from 2020 unless otherwise noted.

 

Read More